Sun Pharmaceutical Industries: Specialty and Domestic Formulation to Drive Growth.
Sun Pharma (SUNP) is expected to sustain steady growth momentum, driven by strong traction in its global specialty business (18% of sales)
368 Views
Sun Pharma - Addressing the Oral IL-23 Antagonist Challenge to Ilumya
Emkay Global Financial's research report on Sun Pharma J&J, in a recent investor interaction, had stated that its oral IL-23 receptor antagonist...
206 Views
Top APAC (Ex-China) Investment Worthy Healthcare Companies Using Smartkarma’s Smart Score Screener
We have screened APAC (ex-China) healthcare companies with market cap≥$800M using Smartkarma’s Smart Score and picked up 2 investable ideas by...
402 Views
Oswal Pumps IPO Trading - Decent Anchor; Strong Overall Demand
Oswal Pumps raised about US$162m in its India IPO. In this note, we will talk about the demand and trading dynamics, having looked at the...
148 Views
Sai Life Sciences IPO Lockup - US$840m Lockup Release; TPG Asia up 5.8x with a 24.8% Stake
TPG Asia is selling 20.8m shares or 10% of the capital in Sai Life Sciences amounting to INR14.8bn (US$170m) at a floor price of INR 710/share, a...
396 Views